Literature DB >> 21051981

Indication of participation of caspase-2 and caspase-5 in mechanisms of human cervical malignancy.

Evaggelos Babas1, Maria T Ekonomopoulou, Irine Karapidaki, Anestakis Doxakis, George Betsas, Zafiroula Iakovidou-Kritsi.   

Abstract

INTRODUCTION: When apoptosis is disrupted, the transformed cells can survive, proliferate, and evolve into a malignancy. The strictly conserved caspase genes and the reliable experimental data clearly show that some caspases play a crucial role in apoptosis even if some of them have no apoptotic activity and others exhibit both apoptotic and nonapoptotic properties. Although caspase-2 belongs to initiator caspases, its normal role remains unclear. Experimental studies have shown that it is primarily necessary for the execution of apoptosis in mutagenic cells. Human caspase-5 is classified as an inflammatory caspase, although its substrate has not been identified yet. In this research, the activities of caspase-2 and caspase-5 have been estimated during the progression of human cervical malignancy.
METHODS: The experimental material includes human cervical tissue samples (normal and pathological) and blood serum samples of the corresponding tissue donors, where enzyme activities have been measured colorimetrically.
RESULTS: Both caspases' activities showed the highest increase, statistically significant (P < 0.01, by t test) compared with the controls, in the low-grade squamous intraepithelial lesion tissues. Caspase-2 of all pathological tissues was proved more active than the controls. Serum caspases' activities were significantly lower than those of the tissues. Serum caspase-2's activity in patients with low-grade squamous intraepithelial lesion stage showed no statistically significant increase compared with the controls. Serum caspase-5's activity of all patients with malignancy stages was presented elevated, whereas that of the serum of patients with cervical cancer had the highest activity (P < 0.01, by t test).
CONCLUSIONS: The changes of caspase-2 and caspase-5 activities could be indicative of their involvement in the cervical malignancy mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051981     DOI: 10.1111/IGC.0b013e3181ed7896

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.

Authors:  Joanna Iłżecka
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

2.  Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer.

Authors:  Marianthi Krikeli; Maria T Ekonomopoulou; Ioannis Tzitzikas; Antonios Goutzioulis; Kyriaki Mystakidou; Kyriaki Pistevou-Gombaki
Journal:  Cancer Manag Res       Date:  2011-07-06       Impact factor: 3.989

3.  Cytotoxicity and Proapoptotic Effects of Allium atroviolaceum Flower Extract by Modulating Cell Cycle Arrest and Caspase-Dependent and p53-Independent Pathway in Breast Cancer Cell Lines.

Authors:  Somayeh Khazaei; Roslida Abdul Hamid; Vasudevan Ramachandran; Norhaizan Mohd Esa; Ashok Kumar Pandurangan; Fatemeh Danazadeh; Patimah Ismail
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-08       Impact factor: 2.629

4.  A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma.

Authors:  Yiming Zhang; Rong He; Xuan Lei; Lianghao Mao; Pan Jiang; Chenlie Ni; Zhengyu Yin; Xinyu Zhong; Chen Chen; Qiping Zheng; Dapeng Li
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

5.  Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel.

Authors:  Akin Yilmaz; Ebru Alp; H Ilke Onen; Sevda Menevse
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.